Nichols has been studying how the amyloid-β protein interacts with a group of three proteins known as NLRP3 inflammasome to cause inflammation inside immune cells in the brain.
Nichols has been studying how the amyloid-β protein interacts with a group of three proteins known as NLRP3 inflammasome to cause inflammation inside immune cells in the brain.
Nichols has been studying how the amyloid-β protein interacts with a group of three proteins known as NLRP3 inflammasome to cause inflammation inside immune cells in the brain.
Nichols has been studying how the amyloid-β protein interacts with a group of three proteins known as NLRP3 inflammasome to cause inflammation inside immune cells in the brain.
Each of the four sessions at the 2025 symposium partnered UMSL faculty members with industry experts to bridge the gap between theory and practice.
Faculty members Mary Edwin, Emily Brown, Anita Manion, Rachel Winograd, Vivek Singh and Michael Nichols were honored at Friday’s event in the Millennium Student Center.
Faculty members Mary Edwin, Emily Brown, Anita Manion, Rachel Winograd, Vivek Singh and Michael Nichols were honored at Friday’s event in the Millennium Student Center.
Faculty members Mary Edwin, Emily Brown, Anita Manion, Rachel Winograd, Vivek Singh and Michael Nichols were honored at Friday’s event in the Millennium Student Center.
Nichols received a $459,279 grant from the National Institute of General Medical Sciences to study the mechanisms of NLRP3 inflammasome activation.
Nichols received a $459,279 grant from the National Institute of General Medical Sciences to study the mechanisms of NLRP3 inflammasome activation.
Nichols received a $459,279 grant from the National Institute of General Medical Sciences to study the mechanisms of NLRP3 inflammasome activation.